Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,579 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study.
Osterlund P, Kinos S, Pfeiffer P, Salminen T, Kwakman JJM, Frödin JE, Shah CH, Sorbye H, Ristamäki R, Halonen P, Soveri LM, Heervä E, Ålgars A, Bärlund M, Hagman H, McDermott R, O'Reilly M, Röckert R, Liposits G, Kallio R, Flygare P, Teske AJ, van Werkhoven E, Punt CJA, Glimelius B. Osterlund P, et al. ESMO Open. 2022 Jun;7(3):100427. doi: 10.1016/j.esmoop.2022.100427. Epub 2022 Mar 30. ESMO Open. 2022. PMID: 35798468 Free PMC article.
A diagnostic dilemma in AL(L)PS.
Lee-Brennan C, O'Reilly M, Smith O, Quinn J, Murphy P, Keogan M. Lee-Brennan C, et al. Ann Hematol. 2014 Mar;93(3):515-6. doi: 10.1007/s00277-013-1823-0. Epub 2013 Jun 20. Ann Hematol. 2014. PMID: 23783422 No abstract available.
A 5-day outpatient regimen of azacitidine is effective and well tolerated in patients with acute myeloid leukemia unsuitable for intensive chemotherapy.
O'Reilly MA, McHale C, Almazmi A, Hameed A, Benjamin D, O'Connell N, Murphy P, Quinn J, Thornton P, O'Gorman P, Frankova H, Sargent J, Verburgh E, McHugh J, Evans P, Enright H. O'Reilly MA, et al. Leuk Lymphoma. 2014 Dec;55(12):2950-1. doi: 10.3109/10428194.2014.904512. Epub 2014 Apr 22. Leuk Lymphoma. 2014. PMID: 24628297 No abstract available.
Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy.
Iacoboni G, Iraola-Truchuelo J, O'Reilly M, Navarro V, Menne T, Kwon M, Martín-López AÁ, Chaganti S, Delgado J, Roddie C, Pérez A, Norman J, Guerreiro M, Gibb A, Caballero AC, Besley C, Martínez-Cibrián N, Mussetti A, Sanderson R, Luzardo H, Iyengar S, Sánchez JM, Jones C, Sancho JM, Barba P, Latif AL, López-Corral L, Hernani R, Reguera JL, Sureda A, Garcia-Sancho AM, Bastos M, Abrisqueta P, Kuhnl A. Iacoboni G, et al. Among authors: o reilly m. Hemasphere. 2024 May 21;8(5):e62. doi: 10.1002/hem3.62. eCollection 2024 May. Hemasphere. 2024. PMID: 38774657 Free PMC article.
Neuro Sweet Syndrome.
Thazhatheyil K, O'Reilly M, Rae N, Edwards S, O'Riordan J, Affleck A. Thazhatheyil K, et al. Among authors: o reilly m. Clin Exp Dermatol. 2024 May 13:llae175. doi: 10.1093/ced/llae175. Online ahead of print. Clin Exp Dermatol. 2024. PMID: 38738507 No abstract available.
1,579 results